Cancer Research | Penn Today

Penn Medicine’s Tara Miller Melanoma Cancer Center opens in memory of young woman who lost her battle

A new melanoma research center, named for the late Tara Miller, was dedicated this week at the Abramson Cancer Center. Lynn Schuchter of the Perelman School of Medicine said Miller was “a remarkable woman, incredibly courageous, such a love for life.”

portraits of eugene mele and nancy speck

Two Penn faculty elected to the National Academy of Sciences

Eugene Mele of the School of Arts and Sciences and Nancy Speck of the Perelman School of Medicine are welcomed into the Academy for their “distinguished and continuing achievements in original research.”

Patricia Corby in an office smiling at the camera

Expanding opportunities to leverage science in the clinic

Patricia Corby, who recently joined the School of Dental Medicine as associate dean for translational research, is bringing her research to bear for cancer patients undergoing radiation, while looking to advance clinical research School-wide.

First U.S. patients treated with CRISPR as human gene-editing trials get underway

A clinical trial led by Edward Stadtmauer of the Perelman School of Medicine will be using CRISPR to treat cancer patients.

New cancer therapies offer great hope, but there can be surprising complications

Ravi Parikh of the Perelman School of Medicine spoke about rapid advances in cancer therapies. While excited about the possibilities, Parikh notes that new treatments come with new side effects, among other complications.

doctor with a gloved hand examines young child's arm during a skin test screening

Topical targeted therapies show promise in treatment of skin cancer

A Penn study finds fewer side effects with small-molecule kinase inhibitors compared to standard ointment when treating precancerous skin lesions.

Penn tops nation in CAR T-cell patents, $25M for HealthVerity data firm, Sumo is back, and more

The Perelman School of Medicine’s Carl June was highlighted for his numerous patents for CAR T-cell inventions, the most of any single researcher on the emerging technology.

view of Amy Gutmann on stage from the audience at the Power of Penn event with a large video screen behind her showing a video

The Power of Penn at the Met

One year into the Power of Penn campaign, President Amy Gutmann hosted a panel discussion with three professors to usher in another year of inclusion, innovation, and impact on a local and global scale.

Pancreatic cancer treatments show promise in studies, Penn reports

Two studies from the Perelman School of Medicine, one led by Mark O’Hara and the other by Kim Reiss Binder, found encouraging results from experimental treatments for pancreatic cancer. “To be able to offer a targeted therapy with much less toxicity, even if only for a subset of our patients, would be a wonderful thing,” said Reiss Binder.

Hospitals are saving lives with CAR T. Getting paid is another story

David Porter of the Perelman School of Medicine said nearly all of CAR T treatments performed at the Abramson Cancer Center are done on an outpatient basis. “Not lots of people are doing it that way, but, again, we have years of experience with this,” Porter said.

Filters